Products Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified)
Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified) Phase 3 Recruiting 📈 Rising Measles, Rubella, Yellow Fever
Apr 1, 2025 → Mar 31, 2026
About Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified) Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified) is a phase 3 stage product being developed by Zydus Lifesciences for Measles. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06815835. Target conditions include Measles, Rubella, Yellow Fever.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT06815835 Phase 3 Recruiting Apr 1, 2025 Mar 31, 2026 Measles
Product Company Stage Hype Score MMRV (AMP) + MMRV (2006 process) Merck Phase 3 M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX® Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™ Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: M-M-R II + Comparator: PUVV Merck Phase 2 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 ProQuad® manufactured with recombinant Human Albumin (rHA) Merck Phase 3 Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck) Merck Phase 3 measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live Merck Phase 2 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Tripedia + Comparator: Comvax + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeks Merck Phase 3 V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine Live Merck Phase 2 Comparator: ProQuad™ (V221) + Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine) Merck Phase 3 Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R II Merck Phase 3 ProQuad® Merck Phase 3 MMR vaccine Merck Pre-clinical ProQuad® Merck Phase 3 ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) + Comparator: M-M-R II + Comparator: Varivax + Comparator: Placebo Merck Phase 3 Measles vaccine Novo Nordisk Approved Measles vaccine Novo Nordisk Approved Measles vaccine Novo Nordisk Approved
Other Products from Zydus Lifesciences